These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 35281324)
1. The Missing LNK: Evolution from Cytosis to Chronic Myelomonocytic Leukemia in a Patient with Multiple Sclerosis and Germline SH2B3 Mutation. Gundabolu K; Dave BJ; Alvares CJ; Cannatella JJ; Bhatt VR; Maness LJ; Al-Kadhimi ZS; Zabad RK; Cushman-Vokoun AM Case Rep Genet; 2022; 2022():6977041. PubMed ID: 35281324 [TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review. Patnaik MM; Lasho T Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):460-464. PubMed ID: 33275673 [TBL] [Abstract][Full Text] [Related]
3. Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report. Pelkey LJ; Graham DM; Zakem MH; Muza-Moons MM Cureus; 2022 Feb; 14(2):e22422. PubMed ID: 35228982 [TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML. Schuler E; Frank F; Hildebrandt B; Betz B; Strupp C; Rudelius M; Aul C; Schroeder T; Gattermann N; Haas R; Germing U Leuk Res; 2018 Feb; 65():1-4. PubMed ID: 29216536 [TBL] [Abstract][Full Text] [Related]
5. The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia. Federmann B; Abele M; Rosero Cuesta DS; Vogel W; Boiocchi L; Kanz L; Quintanilla-Martinez L; Orazi A; Bonzheim I; Fend F Hum Pathol; 2014 Dec; 45(12):2471-9. PubMed ID: 25305095 [TBL] [Abstract][Full Text] [Related]
7. Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia. Cui Y; Tong H; Du X; Li B; Gale RP; Qin T; Liu J; Xu Z; Zhang Y; Huang G; Jin J; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z Exp Hematol Oncol; 2015; 4():14. PubMed ID: 26019984 [TBL] [Abstract][Full Text] [Related]
8. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis. Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910 [TBL] [Abstract][Full Text] [Related]
9. Novel therapeutic targets for chronic myelomonocytic leukemia. Lasho T; Patnaik MM Best Pract Res Clin Haematol; 2021 Mar; 34(1):101244. PubMed ID: 33762099 [TBL] [Abstract][Full Text] [Related]
10. Mutations in chronic myelomonocytic leukemia and their prognostic relevance. Jian J; Qiao Y; Li Y; Guo Y; Ma H; Liu B Clin Transl Oncol; 2021 Sep; 23(9):1731-1742. PubMed ID: 33861431 [TBL] [Abstract][Full Text] [Related]
11. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia. Pérez B; Kosmider O; Cassinat B; Renneville A; Lachenaud J; Kaltenbach S; Bertrand Y; Baruchel A; Chomienne C; Fontenay M; Preudhomme C; Cavé H Br J Haematol; 2010 Dec; 151(5):460-8. PubMed ID: 20955399 [TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study. Péan de Ponfilly-Sotier M; Jachiet V; Benhamou Y; Lahuna C; De Renzis B; Kottler D; Voillat L; Dimicoli-Salazar S; Banos A; Chauveheid MP; Alexandra JF; Grignano E; Liferman F; Laborde M; Broner J; Michel M; Lambotte O; Laribi K; Venon MD; Dussol B; Martis N; Thepot S; Park S; Couret D; Roux-Sauvat M; Terriou L; Hachulla E; Bally C; Galland J; Allain JS; Parcelier A; Peterlin P; Cohen-Bittan J; Regent A; Ackermann F; Le Guen J; Algrin C; Charles P; Daguindau E; Puechal X; Dunogue B; Blanchard-Delaunay C; Beyne-Rauzy O; Grobost V; Schmidt J; Le Gallou T; Dubos-Lascu G; Sonet A; Denis G; Roy-Peaud F; Fenaux P; Adès L; Fain O; Mekinian A; Clin Exp Rheumatol; 2022 Jul; 40(7):1336-1342. PubMed ID: 35579092 [TBL] [Abstract][Full Text] [Related]
13. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant. Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679 [TBL] [Abstract][Full Text] [Related]
14. Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update. McCullough KB; Patnaik MM Curr Hematol Malig Rep; 2015 Sep; 10(3):292-302. PubMed ID: 26122388 [TBL] [Abstract][Full Text] [Related]
15. Chronic Myelomonocytic Leukemia: Focus on Clinical Practice. Patnaik MM; Tefferi A Mayo Clin Proc; 2016 Feb; 91(2):259-72. PubMed ID: 26848006 [TBL] [Abstract][Full Text] [Related]